Home > Legal Library > Advanced Search > Search Results









Join Matindale-Hubbell Connected



Courtenay C. Brinckerhoff Document Search Results (98)

 

View Page: 1  2  3  4  5  6  7  8  9  10  Next  
Show: results per page
Sort by:
Sponsored Results

HTMLFederal Circuit Upholds Validity of Lysteda Patents
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
August 29, 2014, previously published on August 28, 2014
In two decisions issued under the same name (Ferring B.V. v. Watson Laboratories, Inc.), the Federal Circuit upheld the validity of the Orange Book-listed patents for Lysteda®, but found that they were not infringed by either Apotex’s or Watson’s Abbreviated New Drug Applications...

 

HTMLAiring the USPTO's Naturally Occurring Dirty Laundry — the Subject Matter Eligibility Stain
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
August 27, 2014, previously published on August 21, 2014
It has been five months since the USPTO issued its Guidance For Determining Subject Matter Eligibility Of Claims Reciting Or Involving Laws of Nature, Natural Phenomena, & Natural Products to aid examiners in applying the principles of Myriad and Prometheus to any claim “reciting or...

 

HTMLFederal Circuit Upholds Inequitable Conduct Defense Against Apotex Patent
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
August 22, 2014, previously published on August 18, 2014
In Apotex Inc. v. UCB, Inc., the Federal Circuit upheld the district court’s finding that Apotex’s patent is unenforceable due to inequitable conduct. While affirming on the ground of “but-for materiality,” the Federal Circuit noted that the inventor’s conduct...

 

HTMLFirst Post Grant Review Petition Shows That Amending Claims Is Not Child's Play
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
August 12, 2014, previously published on August 11, 2014
The first Post Grant Review petition visible to the public was filed August 5, 2014, against U.S. Patent 8,684,420. The patent was granted from an application filed July 26, 2013, but claims priority through a series of continuation applications to an application filed September 8, 2011, and to a...

 

HTMLFederal Circuit Finds That FDA Citizen Petition Could Give Rise to Antitrust Liability
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
August 11, 2014, previously published on August 7, 2014
In Tyco Healthcare Group LP v. Mutual Pharmaceutical Co., Inc., the Federal Circuit remanded-in-part for the district court to determine whether Tyco’s citizen petition to the FDA gave rise to antitrust liability. Judge Newman wrote a dissenting opinion warning against the chilling effect...

 

HTMLVisiting the USPTO Without a REAL ID
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
August 7, 2014, previously published on August 5, 2014
As announced on the “USPTO Locations” page of its website, the USPTO has implemented a new policy for members of the public visiting the USPTO relating to the REAL ID Act. Under the REAL ID Act, the USPTO may no longer accept driver’s licenses from certain states and instead will...

 

HTMLComments on Patent Subject Matter Eligibility Guidance Due by July 31
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
August 2, 2014, previously published on July 28, 2014
This week brings the July 31, 2014 deadline for submitting written comments on two USPTO patent subject matter eligibility guidance documents: The “Myriad-Mayo” Guidance issued March 4, 2014 (for claims involving laws of nature, natural phenomena, and natural products) and the...

 

HTMLHow Long Is Too Long (or Too Short) for Patent Application Pendency?
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
July 25, 2014, previously published on July 18, 2014
The USPTO is requesting input on the “optimal” targets for its patent application pendency metrics. The USPTO’s current targets are 10 months to a first Office Action and 20 months to grant or abandonment. The USPTO wants to know if you think these targets too long, too short, or...

 

HTMLFederal Circuit Says Commission Must Toe the Line in Invisalign ITC Case
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
July 25, 2014, previously published on July 23, 2014
In Align Technology, Inc. v. International Trade Commission, the Federal Circuit held that ITC action that violated ITC’s own regulations warranted vacatur under the Administrative Procedures Act. While the case addresses specific ITC regulations, the same principles apply to other agencies,...

 

HTMLWhy Are Method of Treatment Claims and Method of Manufacture Claims Subject to Scrutiny Under the USPTO Patent Subject Matter Eligibility Guidance?
Courtenay C. Brinckerhoff; Foley & Lardner LLP;
Legal Alert/Article
July 18, 2014, previously published on July 15, 2014
The USPTO has asked for written comments on its patent subject matter eligibility guidance by July 31, 2014. In this article, I discuss why therapeutic method claims and method of manufacture claims should not be subject to scrutiny under the USPTO’s multi-factored § 101 analysis.

 


View Page: 1  2  3  4  5  6  7  8  9  10  Next